Organization
George Washington University Hospital
13 abstracts
Abstract
Change in tumor microenvironment and PD-L1 expression with rucaparib treatment in triple-negative breast cancer.Org: George Washington University Hospital,
Abstract
Effects of preoperative breast MRI on surgical management in women aged 40 years and younger with breast cancer.Org: George Washington University School of Medicine and Health Sciences, George Washington University Hospital,
Abstract
The effect of an online micro CE/CME on the multidisciplinary care of patients with nonmelanoma skin cancer.Org: Medscape LLC, George Washington University Hospital,
Abstract
A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer.Org: Moffitt Cancer Center, Stanford Cancer Center, Washington University School of Medicine in St Louis, University of Washington and Fred Hutchinson Cancer Research Centre, Massachusetts General Hospital,
Abstract
Gender and postoperative surgical margin status in MIBC: An analysis of the National Cancer Database.Org: George Washington University Hospital, George Washington University School of Medicine and Health Sciences,
Abstract
Association of Agent Orange and myeloproliferative neoplasms, thrombosis, and bleeding among veterans.Org: Georgetown Lombardi Comprehensive Cancer Center, George Washington University Hospital, George Washington University Milken Institute School of Public Health, Washington DC VA Medical Center, George Washington University School of Medicine and Health Sciences,
Abstract
Gender disparities in metastatic RCC therapies and outcomes.Org: George Washington University Hospital, George Washington University School of Medicine and Health Sciences,
Abstract
Components of total cost of care in real-world patients with mPDAC who received first-line FOLFIRINOX or Gem/Abrax.Org: Milliman, Inc., Ipsen Biopharmaceuticals, Inc., George Washington University Hospital,
Abstract
Adverse events in real-world patients covered by Medicare with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX.Org: Milliman, Inc., Ipsen Biopharmaceuticals, Inc., George Washington University Hospital,
Abstract
Real-world treatment patterns and total cost of care in Medicare patients with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX.Org: Milliman, Inc., Ipsen Biopharmaceuticals, Inc., George Washington University Hospital,
Abstract
Patterns of treatment switching and healthcare resource utilization differences among real-world Medicare patients with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX.Org: Milliman, Inc., Ipsen Biopharmaceuticals, Inc., George Washington University Hospital,
Abstract
Key difference-making conditions distinguishing ASCO members’ institutions that collect sexual orientation and gender identity (SOGI) data from those that do not.Org: GW Cancer Center, University of Texas Southwestern Medical Center, Regenstrief Institute, American Society of Clinical Oncology, MD Anderson Cancer Center,
Abstract
Real world outcomes of veterans 18-45 years old with acute lymphocytic leukemia.Org: George Washington University Hospital, The George Washington University School of Medicine and Health Sciences, Washington DC VA Medical Center, George Washington University Milken Institute School of Public Health,